Catalyst
Slingshot members are tracking this event:
Clovis (CLVS) Plans to Initiate Phase 2 MITO-25 Study in Q1 Evaluating Rucaparib and Bevacizumab IIT in Ovarian Cancer 1L Maintenance
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLVS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 22, 2017
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-newsArticle&ID=2248380
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Mito-25, Rucaparib, Bevacizumab, Ovarian Cancer, 1l Maintenance
